Hard to Treat Diseases/ US41164A1034 /
| 2024-04-17 9:10:46 PM | Chg. - | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 0.0000USD | - | 2,000 Turnover: .0020 |
-Bid Size: - | -Ask Size: - | 0.0000 | 0.0000 |
GlobeNewswire
2023-09-25
Regeneron Completes Acquisition of Decibel Therapeutics, Adding Promising Gene Therapy Programs for ...
GlobeNewswire
2021-10-08
Relay Therapeutics Announces Interim Clinical Data that Support RLY-4008 as a Highly Selective FGFR2...
GlobeNewswire
2021-06-30
Rafael Pharmaceuticals to Present Pancreatic & Biliary Tract Cancer Data on CPI-613® (Devimistat) fr...
GlobeNewswire
2021-05-20
Predictive Oncology Inc.’s Wholly Owned Subsidiary, TumorGenesis, Partners with Cellevate AB
GlobeNewswire
2019-10-28
PharmaCyte Biotech to Change Future of Treating Diseases with Validation of Encapsulation Technology...
GlobeNewswire
2019-10-15
WindMIL Therapeutics and University of California, Irvine Announce Collaboration to Collect Bone Mar...
GlobeNewswire
2019-09-25
Bio-Path Updates Intellectual Property Portfolio with Addition of Recently Issued Second Platform Te...
Newsfile Corp
2019-09-17
cbdMD Sales Growing, Key Influencers Continue to Bring the Product Mainstream-- CFN Media
GlobeNewswire
2019-07-29
Innovation Pharmaceuticals Provides Corporate Update Highlighting Clinical Pipeline Progress and Bus...
GlobeNewswire
2018-11-02
Novartis data at ASH and SABCS show strength of pipeline and portfolio in hematology and oncology
